1[1]T ф nnessen T, Giaid A, Saleh D et al. Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res, 1995;76:767～772
2[2]Pernow J, Q-D Wang. Endothline in myocardial ischaemia and reperfusion. Cardiovasc Res, 1997;33:518～526
3[3]Dvenport AP, O Reilly G, Kuc RE. Endothelin ET(a) and ET(b) mRNA and receptors expressed by smooth muscle in the human vasculature:majority of the ET(a) subtype. Br J Pharmacol, 1995;114:1110～1116
4[4]Natarajan S, Hunt JT, Festin S et al. Endothelin analogs which distinguish vasodilator ETB receptors. Life Sci, 1995;56:1251
5[5]Watanabe TA, Wane Y, Ikeda S et al. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-004 and the inhibition of myocardial infarct size in rats. Br J Pharmacol, 1995;114:949～954
6[6]Hasdai D, Kornowski R, Battler A. Endothelin and myocardial ischemia. Cardiovasc Drug Ther, 1994;8:589～599
7[7]Illing B, Horn M, Han H et al. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical fcmetion and energy metabolism during ischemiafrefnsion injury in; solated perfused rat hearts, J Cardiovasc Pharmacol, 1996;27(4):487～494
8[8]Wang QD, Li XS, Lundberg JM et al. Protectine effects of non-peptide endothelin recepter antagonist bosentan on myocardial ischemic and reperfusion injury in the pig. Cardiorasc Res,1995; 29(6):805～812
9[9]Gonon AT, Wang QD, Shimizu M et al. The novel non-peptide selective endothelin A receptor antagonist LU135.252 protects against myocardio ischemic and reperfusion injury in the pig. Acta Physiol Scand, 1998;163(2):131～137
10[10]Brunner F, Kukoretz WR. Postischemic antiarrhythmiz effects of angiotensin converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion. Circulation, 1996;94(7):1752～1761
